title: Guillain-Barré syndrome and catecholamine therapy. A potential risk for developing takotsubo cardiomyopathy?
authors.forename: Silvio
authors.initials: S
authors.lastname: Quick
authors.forename: Carmen
authors.initials: C
authors.lastname: Quick
authors.forename: Ralph
authors.initials: R
authors.lastname: Schneider
authors.forename: Krunoslav
authors.initials: K
authors.lastname: Sveric
authors.forename: Stefanie
authors.initials: S
authors.lastname: Katzke
authors.forename: Ruth H
authors.initials: RH
authors.lastname: Strasser
authors.forename: Karim
authors.initials: K
authors.lastname: Ibrahim
mesh_terms: D002395:Catecholamines / Q000009:adverse effects*; D005260:Female; D020275:Guillain-Barre Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D054549:Takotsubo Cardiomyopathy / Q000139:chemically induced* / Q000175:diagnosis*
chemical_list: D002395:Catecholamines